ATC Group: V08CA02 Gadoteric acid

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V08CA02 in the ATC hierarchy

Level Code Title
1 V Various
2 V08 Contrast media
3 V08C Magnetic resonance imaging contrast media
4 V08CA Paramagnetic contrast media
5 V08CA02 Gadoteric acid

Active ingredients in V08CA02

Active Ingredient Description
Gadoteric acid

Gadoteric acid has paramagnetic properties allowing MRI contrast enhancement. It has no specific pharmacodynamic activity and is biologically very inert.

Related product monographs

Title Information Source Document Type  
DOTAGRAF Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DOTAREM Solution for injection Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Brazil (BR)

Canada (CA)

Cyprus (CY)

Ecuador (EC)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Malta (MT)

New Zealand (NZ)

Singapore (SG)

South Africa (ZA)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.